Concepción de un plan de negocios para la creación de una agencia de representación de nuevos músicos: modelo de aplicación basado en el género pop- rock

Al realizar un plan de negocio a partir de la idea de creación de una agencia de representación de artistas musicales, se analizaron los distintos factores que intervienen en el mismo, para de esta manera evaluar si la idea de negocio es factible o no y así mismo aplicar los conocimiento adquiridos en la maestría al emplearlos en un caso aplicativo que es el de IOSSA, un músico italiano con gran potencial. En el capítulo II, se realizó un análisis general del mercado en el cuál se determinó la oferta y la demanda de la música grabada y en streaming, para así poder determinar el tipo de estrategias a realizar. En el capítulo III, se realizó un estudio de la competencia y de acuerdo al análisis, realizó también un plan de marketing con las estrategias a realizar, seguido por una descripción de la estructura organizacional de la Agencia de Representación. Adicionalmente, se realizó un estudio de factibilidad económica y financiera para medir la factibilidad de la idea de negocio. Por último se realizó un caso aplicativo en el cuál se muestra cómo trabajará la Agencia de representación de artistas musicales. Líneas de investigación y desarrollo futuras: La información que se ha considerado necesaria presentar va desde la situación general del mercado, para luego realizar un estudio de la competencia y finalmente realizar un análisis de factibilidad del plan de negocios internacional. Así el proyecto pueda ser entendido, aceptado y también podría ser útil para solicitar créditos o buscar inversores o socios si el caso lo amerite.Facultad de Ciencias Económica

Schematic representation of the steps employed in our data mining strategy and the number of genes selected after each step.

<p>Schematic representation of the steps employed in our data mining strategy and the number of genes selected after each step.</p

Relative expression of Proglucagon mRNA (gray bar) and GLP-1 protein (black bar) in colonic mucosa of a random selection of control fed and FOS fed rats

mRNA and protein levels were normalized to Actin levels. Expression is shown as means ± SEM (n = 7). **p < 0.01, ***P < 0.001<p><b>Copyright information:</b></p><p>Taken from "Impaired barrier function by dietary fructo-oligosaccharides (FOS) in rats is accompanied by increased colonic mitochondrial gene expression"</p><p>http://www.biomedcentral.com/1471-2164/9/144</p><p>BMC Genomics 2008;9():144-144.</p><p>Published online 27 Mar 2008</p><p>PMCID:PMC2311291.</p><p></p

Identified candidate Down Syndrome (DS) biomarkers.

<p>Potential for DS screening is indicated as follows: In use, currently widely used in 1^st or 2^nd trimester DS screening (in bold); Biomarker, studies showed overall significant concentrations; Examined, examined as biomarker but not significant or inconclusive overall results; Indications, found in high-throughput study but awaiting further study. References on the corresponding literature are given in the <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0008010#s4" target="_blank">Discussion</a>.</p

Potentially blood-detectable marker for CRD.

<p>Fold ratio of selected differentially expressed genes encoding potentially blood-detectable protein biomarkers for CRD. Expression of these genes is up-regulated or down-regulated by both the CCW and the CW schedule and remains up or down regulated during recovery.</p

Potential biomarkers for CRD as identified by classification and sequential approach.

<p>Potential biomarkers for CRD as identified by classification and sequential approach.</p

Double plots of peak phase of core body temperature rhythms.

<p><b>A.</b> the counterclockwise schedule and <b>B.</b> the clockwise schedule. A cosine function was fitted to determine peak phase (n = 4 mice per group). Data are presented as mean peak phase ± sd. Grey areas indicate periods of darkness.</p

Serum levels of the CD36 protein.

<p>Serum levels were determined at baseline and 14 days after the last shift for animals subjected to CCW and CW shifted light schedules. Error bars indicate mean ± sd.</p

Variation caused by confounding factors.

<p>Selected samples to exemplify the influence of confounding factors (<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0145252#pone.0145252.t002" target="_blank">Table 2</a>) derived from the PCA analysis of the complete experiment. Sample means are used except for D and E. A, UV-Dose (green = untreated, red = high dose); B, Recovery-Time (hours) ≈ Time-of-Day; C, Recovery-Time (light green = early, green = late); D, Trp53-Genotype (green = WT, blue = <i>Trp53</i>-72P mutant); E, Handling- & Biopsy-Stress (light green = Early recovery, green = Late recovery); and F, Individual-Mouse (yellow = #31, black = #55).</p

Examples of individual-mouse-related gene expression from Group IM-A.

<p>A: Examples of expression profiles for untreated WT samples for genes from Group IM-A. B: Boxplot of absolute ANOVA Individual-Mouse effect of all genes per untreated WT mouse. C: 2x2 SOMS per mouse of the scaled gene-expression profiles of all 391 genes in group IM-A.</p